近年来新头孢菌素及有关药物有较多发展,它们对肠杆菌科具有强抗菌活性,对绿脓杆菌也有一定活性。氨噻头孢菌素(Cefotaxime,HR756)首被发现,并用作评价其他药物的标准.本品抗菌谱广,除对肠杆菌科的全部菌种、嗜血杆菌和奈瑟氏菌具有强抗菌活性外,尚对不动杆菌(Acinetobacter spp.)大多数绿脓杆菌和某些假单孢菌、大多数厌氧菌、葡萄球菌和链球菌具抗菌活性,但耐甲氧苯青霉素的葡萄球菌及粪链球菌 In recent years, new cephalosporins and related drugs have more development, they have strong antibacterial activity of Enterobacteriaceae, Pseudomonas aeruginosa also have some activity. Cefetotaxime (HR756) was first discovered and used as a standard for the evaluation of other drugs. This product has a broad antibacterial spectrum and has strong antibacterial activity against all strains of Enterobacteriaceae, Haemophilus and Neisseria In addition, the majority of Acinetobacter spp., Pseudomonas aeruginosa and some Pseudomonas, most of the anaerobic bacteria, Staphylococcus aureus and Streptococcus antibacterial activity, but methicillin-resistant Staphylococcus aureus and Streptococcus faecalis